ClinicalTrials.gov
ClinicalTrials.gov Menu

MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00374296
Recruitment Status : Terminated (The Clinical Development Program for MGCD0103 is being re-evaluated)
First Posted : September 11, 2006
Last Update Posted : July 1, 2015
Sponsor:
Information provided by (Responsible Party):
Mirati Therapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2008
  Actual Study Completion Date : September 2008
  Certification/Extension First Submitted : June 4, 2015